Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$17.11 USD
-0.44 (-2.51%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $17.12 +0.01 (0.06%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CCRN 17.11 -0.44(-2.51%)
Will CCRN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
Cross Country (CCRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Cross Country Healthcare (CCRN) Lags Q2 Earnings Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
New Strong Sell Stocks for February 27th
Other News for CCRN
Cross Country Healthcare (CCRN) Receives a Rating Update from a Top Analyst
Benchmark Co. Reaffirms Their Buy Rating on Cross Country Healthcare (CCRN)
Cross Country Healthcare (CCRN) Receives a Rating Update from a Top Analyst
Cross Country: Q2 Earnings Snapshot
Cross Country Healthcare Announces Second Quarter 2024 Financial Results